Transitioning From Oral to Intravenous Treprostinil in Pulmonary Arterial Hypertension: A Case Report
Clinical Case Reports · 2026-04 · 14 (4)
DOI: 10.1002/ccr3.72499 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 10.04.2026. Verfasst von Abigail M Cummings und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy University of Virginia Health Charlottesville Virginia USA. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The optimal approach to transitioning from oral treprostinil to intravenous treprostinil in pulmonary arterial hypertension (PAH) has been poorly characterized in published literature. We present a case involving a 21‐year‐old male with PAH experiencing worsening symptoms despite treatment with high doses of oral treprostinil (36.75 mg three times daily), ambrisentan, and tadalafil. The patient was admitted to our institution for transition from oral to intravenous treprostinil due to severe PAH as demonstrated on right heart catheterization (RHC). The transition process involved cross‐tapering intravenous and oral treprostinil over 11 days with the aid of central venous pressure (CVP) measurements and noninvasive blood pressure monitoring. The patient remained clinically stable throughout the transition, and a repeat RHC upon completion demonstrated hemodynamic stability on a final dose of intravenous treprostinil 100 ng/kg/min. This case demonstrates that it is possible to safely transition from oral to intravenous treprostinil more rapidly than recommended by product labeling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy University of Virginia Health Charlottesville Virginia USA.
- Department of Pulmonary and Critical Care Medicine University of Virginia Health Charlottesville Virginia USA.
ORCID-Profile: Abigail M Cummings
Zitieren
APA
Cummings, A. M., Konkol, S. B., Mihalek, A. D., & Roth, M. E. (2026). Transitioning From Oral to Intravenous Treprostinil in Pulmonary Arterial Hypertension: A Case Report. Clinical Case Reports, 14(4). https://doi.org/10.1002/ccr3.72499
Vancouver
Cummings AM, Konkol SB, Mihalek AD, Roth ME. Transitioning From Oral to Intravenous Treprostinil in Pulmonary Arterial Hypertension: A Case Report. Clinical Case Reports. 2026;14(4). doi:10.1002/ccr3.72499
BibTeX
@article{Cummings2026,
author = {Cummings, Abigail M and Konkol, Samuel B and Mihalek, Andrew D and Roth, Mary E},
title = {Transitioning From Oral to Intravenous Treprostinil in Pulmonary Arterial Hypertension: A Case Report},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/ccr3.72499}
}
EUVIMED